Back

Comprehensive analysis of risk factors for the severity of immune checkpoint inhibitor-associated myocarditis in cancer patients

26 August 2023 (13:15 - 13:50)
Organised by: Logo
Congress Presentation Part of: The role of genetics and immunology in myocarditis Myocarditis ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Doctor Xin Tang

West China Hospital, Sichuan University, Chengdu (China)

6 More presentations in this session

Presentation thumbnail
Genetic testing in inflammatory cardiomyopathy/myocarditis: a red flag for cardiomyopathy-like histologic findings
Professor K. Pilichou (Padova, IT)
Abstract Slides Video
Presentation thumbnail
Myocardial injury causes changes in the transcriptional and regulatory landscape of adaptive immune cells in the heart
Ms N. De Winter (London, GB)
Abstract Slides Video
Presentation thumbnail
Modulation of myocardial inflammation, fibrosis development and ventricular arrhythmogenicity by endurance exercise in murine coxsackievirus B3 myocarditis
Doctor K. Favere (Antwerp, BE)
Abstract Slides Video
Presentation thumbnail
Association between anti-cardiac autoantibodies in acute myocarditis and downstream clinical outcomes
Doctor A. Iacob (London, GB)
Abstract Slides Video
Presentation thumbnail
Immunomodulation to target biopsy-proven myocardial inflammation in genetic cardiomyopathies: a pilot report
Doctor G. Peretto (Milan, IT)
Abstract Slides Video

Access the full session

Session thumbnail
The role of genetics and immunology in myocarditis

The Event

Event poster

ESC Congress 2023

26 August 2023 13:15 CET
You may be interested in
thumbnail
Congress Presentation
Immune checkpoint inhibitor associated myocarditis - lessons from a case series
thumbnail
Congress Presentation
Cardiotoxicity and immune checkpoint inhibitors: a heartfelt myth or the real deal?
thumbnail
Congress Presentation
Cardiac magnetic resonance imaging for diagnosis and prognosis of patients with myocarditis from immune checkpoint inhibitor therapy: a meta-analysis

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources